SPECIAL INTERESTS

Modern medicine enables to examine precisely various disease conditions in high detail. The rapid development of diagnostic techniques such as laboratory and imaging methods on the one hand and a daily growing selection of highly specific treatment options on the other hand have brought many changes into Medicine over the last decades.

We thus aim to integrate high-end-technical facilities with the most individualized treatment carried out by our team of internationally renowned experts covering the following fields of internal medicine:

ONCOLOGY

Haematology

Haemostaseology

Clinical Immunology

Check-up program

Oncology

Cancers of the female mammary gland (breast cancer).
Cancers of the digestive tract (e.g. carcinomas of the colon, rectum, anus, stomach, pancreas, gall bladder, biliary tract, liver).
Cancers of the female genital tract (e.g. ovarian carcinomas, uterine carcinomas, cervical carcinomas).
Cancers of the male genital tract (e.g. prostate cancer, testicular cancers).
Cancers of the endocrine glands (e.g. carcinoids, thyroid carcinomas).
Cancers of the respiratory tract (e.g. bronchial carcinomas).
Cancers of the urinary tract (e.g. renal cell carcinomas, urothelium cancer of renal pelvis, ureter and urinary bladder).
Also for patients with ENT tumors, brain tumors, tumors of the skin (melanoma, Merkel-cell carcinoma) and sarcomas of soft tissue, bone and connective tissue treatments is available.
Moreover, there is also expertise and experience regarding rare cancers not listed here.

Haematology

Lymphoproliferative disorders (e.g. chronic lymphocytic leukemia, hairy cell leukemia, prolymphocytic leukemia, multiple myeloma)
Myeloproliferative disorders (e.g., chronic myeloid leukemia, myelofibrosis, thrombocythaemia, polycythemia vera)
Lymphomas (Hodgkin's and Non-Hodgkin's Lymphomas)
Myelodysplastic and aplastic syndromes (MDS, aplastic anemia, PNH)
Diseases due to increased or decreased formation of platelets
Diseases due to increased or decreased leukocyte formation
Diseases due to increased formation of red blood cells (polyglobulia).
Anemias (such as haemopathies, globinopathies, membranopathies and enzyme deficiencies including thalassemia, sickle cell anemia, spherocytosis, glucose-6-phosphate dehydrogenase deficiency, pyruvate kinase deficiency, porphyria, iron deficiency, deficiencies of vitamins important for blood cell formation (e.g. vitamin B12 and folic acid deficiency)
Disorders of iron metabolism (hemochromatosis and secondary hyperferritinemia)
Disorders of copper metabolism (Wilson'd disease)

Haemostaseology

Disorders of blood coagulation (i.e. diseases characterized either by increased coagulation with thrombosis or by impaired coagulation with increased bleeding tendency).
Bleeding disease and other deficiency factor deficiencies (e.g., von Willebrand-Jürgens disease, hemophilia, thrombasthenia)
Thrombophilia (this includes not only the causal diagnosis of thrombosis but also the risk assessment of thrombosis in pregnancy, for example)

Immunology

Autoimmune diseases such as autoimmune hemolysis, autoimmune thrombocytopenia, autoimmune neutropenia, rheumatic diseases, collagenoses, vasculitis, autoimmune inflammatory bowel disease, autoimmune liver and thyroid disorders, neuroimmunological disorders.
Antibody deficiency states (primary and secondary).
Monoclonal or polyclonal gammopathies.
Disorders of cell-mediated immunity.
Lysosomal storage disorders (sphingolipidoses (e.g., M. Fabry, M. Gaucher), amyloidosis, mucopolysaccharidoses.

Check-up program (disease prevention)

The goal is to define risk factors in supposedly "healthy" individuals to prevent the onset of diseases or to delay the time of their manifestation. A wide range of diseases are examined in order

to minimize the risk to experience cardiovascular diseases (e.g. myocardial infarction, hypertension, stroke),
to early detect the risk for metabolic disorders (e.g. disturbances of lipid metabolism, diabetes,
to fight overweight,
to optimize treatment of an already established disorders.

Onkologikum-Muenchen-Logoneu-removebg-preview(2)(1)

Onkologikum München
Menzingerstrasse 37
80638 München
office hours
AND BY APPOINTMENT

TEAM@ONKOLOGIKUM-MUENCHEN.DE
WWW.ONKOLOGIKUM-MUENCHEN.DE
VISIT OUR CONTACT-PAGE
+49(89) 15925851 PROF. DR. HERRMANN
+49(89) 15925865 PROF. DR. HERRMANN

Onkologikum München
Menzingerstrasse 37
80638 München
office hours
by appointment

TEAM@ONKOLOGIKUM-MUENCHEN.DE
WWW.ONKOLOGIKUM-MUENCHEN.DE
visit our contact-page
+49(89) 15925851 PROF. DR. HERRMANN
+49(89) 15925865 PROF. DR. HERRMANN